NCT01839097 2020-01-03Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL)Acrotech Biopharma Inc.Phase 1 Completed23 enrolled
NCT02142530 2018-01-25Carfilzomib Plus Belinostat in Relapsed/Refractory NHLMassachusetts General HospitalPhase 1 Completed19 enrolled